These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
383 related items for PubMed ID: 15830061
1. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis. Cardoso E, Rodrigues B, Lucena R, Oliveira IR, Pedreira G, Melo A. Arq Neuropsiquiatr; 2005 Mar; 63(1):30-3. PubMed ID: 15830061 [Abstract] [Full Text] [Related]
3. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review. Olvey EL, Armstrong EP, Grizzle AJ. Clin Ther; 2010 Dec; 32(14):2282-303. PubMed ID: 21353101 [Abstract] [Full Text] [Related]
4. Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity. Rosales RL, Chua-Yap AS. J Neural Transm (Vienna); 2008 Dec; 115(4):617-23. PubMed ID: 18322637 [Abstract] [Full Text] [Related]
5. Botulinum toxin type A for upper limb spasticity after stroke. Shaw L, Rodgers H. Expert Rev Neurother; 2009 Dec; 9(12):1713-25. PubMed ID: 19951131 [Abstract] [Full Text] [Related]
6. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study. Santamato A, Micello MF, Panza F, Fortunato F, Pilotto A, Giustini A, Testa A, Fiore P, Ranieri M, Spidalieri R. Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980 [Abstract] [Full Text] [Related]
9. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial. Nam HS, Park YG, Paik NJ, Oh BM, Chun MH, Yang HE, Kim DH, Yi Y, Seo HG, Kim KD, Chang MC, Ryu JH, Lee SU. J Neurol Sci; 2015 Oct 15; 357(1-2):192-7. PubMed ID: 26233808 [Abstract] [Full Text] [Related]
13. Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials. Jia S, Liu Y, Shen L, Liang X, Xu X, Wei Y. J Stroke Cerebrovasc Dis; 2020 Jun 15; 29(6):104682. PubMed ID: 32305277 [Abstract] [Full Text] [Related]
14. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial. Santamato A, Micello MF, Panza F, Fortunato F, Picelli A, Smania N, Logroscino G, Fiore P, Ranieri M. Clin Rehabil; 2015 Jan 15; 29(1):50-8. PubMed ID: 24917588 [Abstract] [Full Text] [Related]
18. Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial. Lee J, Chun MH, Ko YJ, Lee SU, Kim DY, Paik NJ, Kwon BS, Park YG. Arch Phys Med Rehabil; 2020 Sep 15; 101(9):1485-1496. PubMed ID: 32497599 [Abstract] [Full Text] [Related]
19. Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb. Lagalla G, Danni M, Reiter F, Ceravolo MG, Provinciali L. Am J Phys Med Rehabil; 2000 Sep 15; 79(4):377-84; quiz 391-4. PubMed ID: 10892624 [Abstract] [Full Text] [Related]
20. Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial. Marciniak CM, Harvey RL, Gagnon CM, Duraski SA, Denby FA, McCarty S, Bravi LA, Polo KM, Fierstein KM. Am J Phys Med Rehabil; 2012 Dec 15; 91(12):1007-19. PubMed ID: 23064478 [Abstract] [Full Text] [Related] Page: [Next] [New Search]